相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE) Month 12 Optical Coherence Tomography and Fluorescein Angiography
Robert Petrarca et al.
OPHTHALMOLOGY (2013)
Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg Intravitreal Ranibizumab for Recalcitrant Neovascular Macular Degeneration-Primary End Point
David M. Brown et al.
OPHTHALMOLOGY (2013)
Variants in the VEGFA Gene and Treatment Outcome after Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration
Farshad Abedi et al.
OPHTHALMOLOGY (2013)
VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Nishant Kumar et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION Today's and Future Treatments
Raul Velez-Montoya et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Julie L. Gasperini et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Susanne Binder
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Twelve-Month Results of the DENALI Study
Peter K. Kaiser et al.
OPHTHALMOLOGY (2012)
Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration MERITAGE Study: Twelve-Month Safety and Efficacy Results
Pravin U. Dugel et al.
OPHTHALMOLOGY (2012)
Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration Twelve-month MONT BLANC Study Results
Michael Larsen et al.
OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab
Arghavan Almony et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2011)
Myositis Ossificans
Deborah A. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Dimitrios Karagiannis
Clinical Interventions in Aging (2010)
COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Kimberly E. Stepien et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: Efficiency and possible additional pathways
Alexa Klettner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
分享论文
